285 related articles for article (PubMed ID: 16343074)
21. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
22. Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors.
Obana K; Yang HW; Piao HY; Taki T; Hashizume K; Hanada R; Yamamoto K; Tanaka Y; Toyoda Y; Takita J; Tsuchida Y; Hayashi Y
Int J Oncol; 2003 Oct; 23(4):1151-7. PubMed ID: 12963998
[TBL] [Abstract][Full Text] [Related]
23. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
[TBL] [Abstract][Full Text] [Related]
24. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
25. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.
Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N
Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525
[TBL] [Abstract][Full Text] [Related]
26. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S
Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636
[TBL] [Abstract][Full Text] [Related]
27. [Impact of p16INK4A and p15INK4B on human hepatocellular carcinoma cell proliferation and apoptosis].
Qin Y; Liu JY; Li B; Peng WZ; Fu MD; Sun ZL; Sun ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):132-7. PubMed ID: 15079795
[TBL] [Abstract][Full Text] [Related]
28. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
29. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance.
Chen M; Chen ZQ; Cui PG; Yao X; Li YM; Li AS; Gong JQ; Cao YH
Br J Dermatol; 2008 May; 158(5):987-93. PubMed ID: 18373711
[TBL] [Abstract][Full Text] [Related]
30. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation status of multiple genes in brain metastases of solid tumors.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Amiñoso C; Lopez-Marin I; De Campos JM; Isla A; Gutierrez M; Rey JA
Int J Mol Med; 2004 Jan; 13(1):93-8. PubMed ID: 14654977
[TBL] [Abstract][Full Text] [Related]
32. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
34. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
[TBL] [Abstract][Full Text] [Related]
35. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells.
Sato K; Kusama Y; Tategu M; Yoshida K
Int J Oncol; 2010 Feb; 36(2):479-90. PubMed ID: 20043084
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
[TBL] [Abstract][Full Text] [Related]
39. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
[TBL] [Abstract][Full Text] [Related]
40. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
